Predict what? The company clearly outlined in their investor day in December that they would need more funding to get Zilosul to market. They also gave clear reasons why with durability studies, hip OA study etc being invested in.
They also talk about the options available for funding. I'm hopeful for a rights issue but will leave it up to management to decide.
Maybe no-one mentioned it because it is so obvoius. Not sure why you have decided to make a big issue out of it as well as CEO recruitment as they are clearly taking their time to find the right person.
Predict what? The company clearly outlined in their investor day...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 29.5¢ | $102.6K | 339.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25493 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 3010 | 4 |
View Market Depth
| Last trade - 13.55pm 17/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |